The average MedImmune Investor Relations earns an estimated $64,519 annually. MedImmune's Investor Relations compensation is $17,412 less than the US average for a Investor Relations.
Last updated 7 years ago.
The majority of Investor Relations at MedImmune believe they're compensated fairly. 100% of Investor Relations at MedImmune say they receive annual bonuses, and the vast majority (100%) are satisfied with their benefits. See more compensation ratings at MedImmune